A xenon chloride excimer laser system has been approved for use in the treatment of coronary artery disease for the following indications: (1) lesions longer than 20 mm, (2) moderately calcified lesions, (3) total occlusions crossable with a guidewire, (4) undilatable or uncrossable balloon angioplasty failures, (5) ostial lesions, 6) lesions in saphenous vein bypass grafts. This series of indications represent a set of lesions which have been associated with lower success rates when treated by balloon alone. This series of indications is also much broader than those available for atherectomy devices.<>
Excimer laser angioplasty: technological challenges in expanding the indications for use
Proceedings of LEOS '93 ; 257-258
01.01.1993
186782 byte
Aufsatz (Konferenz)
Elektronische Ressource
Englisch
Excimer Laser Angioplasty: Technological Challenges in Expanding the Indications for Use
British Library Conference Proceedings | 1993
|British Library Conference Proceedings | 1993
|British Library Online Contents | 1992
|Clinical Experience Of Laser Angioplasty
IEEE | 1997
|